Holen Sie sich die Stockscreener-App
121.87
3.06%
3.62
Handel nachbörslich:
121.80
-0.07
-0.06%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt A?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$118.25
Offen:
$119.47
24-Stunden-Volumen:
4.01M
Relative Volume:
1.82
Marktkapitalisierung:
$34.44B
Einnahmen:
$7.07B
Nettoeinkommen (Verlust:
$1.29B
KGV:
26.87
EPS:
4.5355
Netto-Cashflow:
$993.00M
1W Leistung:
+5.92%
1M Leistung:
+8.09%
6M Leistung:
-14.13%
1J Leistung:
+18.92%
1-Tages-Spanne:
$118.88
$121.93
1-Wochen-Bereich:
$114.67
$121.93
52-Wochen-Spanne:
$99.12
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Firmenname
Agilent Technologies Inc
Sektor
Branche
Telefon
(408) 345-8886
Adresse
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
121.87 | 34.44B | 7.07B | 1.29B | 993.00M | 4.5355 |
TMO
Thermo Fisher Scientific Inc
|
526.60 | 195.70B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
194.75 | 137.82B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
589.25 | 46.80B | 4.30B | 1.06B | 1.04B | 13.08 |
WAT
Waters Corp
|
327.77 | 32.18B | 3.17B | 642.63M | 516.49M | 10.77 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Eingeleitet | HSBC Securities | Buy |
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-08 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Hochstufung | UBS | Neutral → Buy |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-11-17 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Bestätigt | Barclays | Equal Weight |
| 2023-05-24 | Bestätigt | BofA Securities | Buy |
| 2023-05-24 | Bestätigt | Citigroup | Neutral |
| 2023-05-24 | Bestätigt | Credit Suisse | Outperform |
| 2023-05-24 | Bestätigt | Evercore ISI | Outperform |
| 2023-05-24 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Bestätigt | Robert W. Baird | Outperform |
| 2023-05-24 | Bestätigt | SVB Securities | Outperform |
| 2023-05-24 | Bestätigt | Stifel | Hold |
| 2023-05-24 | Bestätigt | TD Cowen | Outperform |
| 2023-05-24 | Bestätigt | Wells Fargo | Overweight |
| 2023-05-11 | Eingeleitet | Barclays | Equal Weight |
| 2023-01-10 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-07-08 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Bestätigt | BofA Securities | Buy |
| 2022-02-23 | Bestätigt | Citigroup | Buy |
| 2022-02-23 | Bestätigt | Cowen | Outperform |
| 2022-02-23 | Bestätigt | Evercore ISI | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2021-11-23 | Bestätigt | BofA Securities | Buy |
| 2021-11-23 | Bestätigt | Cowen | Outperform |
| 2021-11-23 | Bestätigt | Stifel | Hold |
| 2021-03-18 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Hochstufung | UBS | Neutral → Buy |
| 2020-11-17 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Neutral |
| 2020-08-19 | Bestätigt | BofA Securities | Neutral |
| 2020-08-19 | Bestätigt | Citigroup | Neutral |
| 2020-08-19 | Bestätigt | Jefferies | Buy |
| 2020-08-19 | Bestätigt | Robert W. Baird | Outperform |
| 2020-08-19 | Bestätigt | SVB Leerink | Outperform |
| 2020-08-19 | Bestätigt | Stifel | Hold |
| 2020-08-19 | Bestätigt | Wells Fargo | Overweight |
| 2020-02-24 | Herabstufung | Needham | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-26 | Bestätigt | Needham | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-18 | Herabstufung | UBS | Buy → Neutral |
| 2019-07-16 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Agilent Technologies Inc Aktie (A) Neueste Nachrichten
TRADE NEWS: Agilent Technologies Introduces HaloPlex Next-Generation Sequencing Panels Targeting Can - Yahoo
Agilent Stock Performance & Valuation Analysis 2026 | Business ReviewNews and Statistics - IndexBox
Agilent Technologies Inc (A) Stock Up 3.1% and Still Undervalued -- GF Score: 93/100 - GuruFocus
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent bets on pathology innovation with Biocare acquisition - MSN
Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch
Agilent Technologies, Inc. $A Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Q4 2025 Earnings Call Transcript - MSN
Agilent Technologies Inc stock (US00846U1016): Why its life sciences leadership matters more now for - AD HOC NEWS
Agilent (A) Showcases Innovations at AACR 2026 Annual Meeting - GuruFocus
Agilent Ekes Higher Ahead of Cancer Research Conference - Baystreet.ca
Agilent Showcases Cancer Research Solutions at AACR 2026 - PharmiWeb.com
Sumitomo Mitsui Trust Group Inc. Trims Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Assetmark Inc. Acquires 12,984 Shares of Agilent Technologies, Inc. $A - MarketBeat
MML Mid Cap Growth Fund's Agilent Technologies Inc(A) Holding History - GuruFocus
Barclays Cuts Agilent Technologies (NYSE:A) Price Target to $140.00 - MarketBeat
Agilent Technologies Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Barclays Adjusts Price Target on Agilent Technologies to $140 From $150, Maintains Overweight Rating - marketscreener.com
Barclays Maintains Agilent Technologies(A.US) With Buy Rating, Cuts Target Price to $140 - Moomoo
Agilent Technologies (A) Valuation Check After CRISPR Patent Loss And BioTek Cytation 9 Launch - Sahm
Agilent Technologies Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Chromatograph (Labor): Precision Tools Drive Agilent's Lab Market Edge Amid Tech Boom - AD HOC NEWS
TD Cowen Adjusts Price Target on Agilent Technologies to $147 From $157, Maintains Buy Rating - marketscreener.com
Is Agilent Technologies Inc impacted by rising ratesTrade Entry Report & AI Enhanced Execution Alerts - baoquankhu1.vn
TRADE NEWS: Agilent Technologies to Demonstrate Leading-Edge RF/Microwave Design and Test Solutions - Yahoo
Massachusetts Financial Services Co. MA Raises Stock Position in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies (A) to acquire Biocare Medical for $950M - MSN
Agilent Technologies Q1 2026 earnings preview - MSN
AGILENT TECHNOLOGIES INC CMNRo Khanna Congressional Trade on Mar. 10, 2026 - Quiver Quantitative
TRADE NEWS: Agilent Technologies and Shimadzu to Exchange Chromatography Instrument Drivers - Yahoo
Agilent Technologies Adjusts Valuation Amid Strong Financial Metrics and Market Confidence - Markets Mojo
Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - GlobeNewswire Inc.
Agilent Technologies Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Agilent Technologies and BaseSolve Informatics Announce Co-Marketing Agreement to Deliver An Integrated NGS Workflow in the United States - Sangri Today
DNA Sequencing Market Leading Players AnalysisAbbott - openPR.com
Agilent Technologies, Inc. $A Shares Bought by CCLA Investment Management - MarketBeat
How New Diagnostic Win and Patent Loss Will Impact Agilent Technologies (A) Investors - Sahm
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Oak Thistle LLC Takes $3.46 Million Position in Agilent Technologies, Inc. $A - MarketBeat
Integrated Breakthrough: Agilent and BaseSolve Enhance U.S. Genomics Workflow - Devdiscourse
Agilent Technologies and BaseSolve Informatics partner to offer integrated NGS workflow in the U.S. - ET Edge Insights
Indo-Asian News Service - IANS
Agilent Technologies And Texmin–IIT (ISM) Dhanbad Partner To Advance India’s Critical Minerals And Sustainable Mining Innovation. - TRIPURA STAR NEWS
Agilent Technologies, Inc. (A) stock price, news, quote and history - Yahoo Finance UK
T. Rowe Price Mid-Cap Growth Fund, Inc.'s Agilent Technologies Inc(A) Holding History - GuruFocus
Agilent Opens Customer Experience Center in Mumbai - eHealth Magazine
T. Rowe Price Mid-Cap Growth Portfolio's Agilent Technologies Inc(A) Holding History - GuruFocus
Agilent Technologies, Inc. $A Shares Sold by Brown Shipley& Co Ltd - MarketBeat
Do Options Traders Know Something About Agilent Technologies Stock We Don't? - MSN
Agilent CLO Departing With Severance After Less Than 2 Years in Role - Law.com
Finanzdaten der Agilent Technologies Inc-Aktie (A)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):